ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jul 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
August 2025
Nuclear Technology
Fusion Science and Technology
July 2025
Latest News
DOE issues new NEPA rule and procedures—and accelerates DOME reactor testing
Meeting a deadline set in President Trump’s May 23 executive order “Reforming Nuclear Reactor Testing at the Department of Energy,” the DOE on June 30 updated information on its National Environmental Policy Act (NEPA) rulemaking and implementation procedures and published on its website an interim final rule that rescinds existing regulations alongside new implementing procedures.
Tadakuni Hakata
Nuclear Technology | Volume 142 | Number 3 | June 2003 | Pages 243-249
Technical Paper | Reactor Safety | doi.org/10.13182/NT03-A3386
Articles are hosted by Taylor and Francis Online.
A study on considerations and strategies for developing safety goals applicable to all nuclear facilities is presented. A scheme of basic safety goals and subsidiary safety goals is assumed, and quantitative basic safety goals for radiation protection of individuals in the vicinity of nuclear facilities are discussed. The risk limit rules are based on comparative risk factors for various health effects, including annual dose, health detriments, acute fatality, latent cancers, and severe hereditary effects. The comparative factor of 1% is used for nonfatal health detriments and 0.1% for fatal effects. A risk limit profile is generated from the risk factors, biological effects, and statistics of injury and mortality rates from general causes. The approaches have potential for developing integrated and comprehensive safety goals.